iRhythm Holdings, Inc. (IRTC)
116.28
-1.50
(-1.27%)
USD |
NASDAQ |
Mar 20, 16:00
116.34
+0.06
(+0.05%)
After-Hours: 20:00
iRhythm Holdings Research and Development Expense (Quarterly) : 21.05M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.07M |
| Alphatec Holdings, Inc. | 22.28M |
| AtriCure, Inc. | 22.74M |
| ICU Medical, Inc. | 21.09M |
| Merit Medical Systems, Inc. | 26.54M |